Established in 1970, this Chinese manufacturer specializes in the research, development, production, and sales of a wide range of pharmaceutical products. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The company operates advanced production lines across four industrial parks, covering approximately 1,333,400 square meters, and employs nearly 5,000 individuals, including over 2,000 professional and technical personnel. Its diverse product portfolio includes anesthetic agents, psychotropic medicines, nonsteroidal anti-inflammatory drugs, cardiovascular system medicines, antibiotics, and antiviral medicines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide. The manufacturer holds GMP certifications from international regulatory authorities, including the U.S. FDA and the Philippines FDA, ensuring adherence to stringent global quality standards

This pharmaceutical company is a comprehensive entity focused on the research, development, and production of various medications. Established in 1949, it boasts over 16 successful FDA inspections across its diverse production facilities. With a team of 17 R&D personnel and a staff exceeding 200 employees, they specialize in prescription medications, over-the-counter drugs, and dietary supplements. Their portfolio encompasses several key therapy areas such as cardiovascular health, central nervous system disorders, infectious diseases, and vitamin deficiencies. They offer various dosage forms including tablets, capsules, and oral solutions. Notably, the company holds GMP certifications and possesses multiple product patents, showcasing their commitment to quality and innovation. They operate primarily in the EU and North America.